Currently, pharmacokinetic profiling uses drug concentrations up to organ or total cellular levels. This does unfortunately not provide information about the actual drug concentration at the molecular target inside a cell, which is expected to contribute to incorrect prediction of a drug’s efficacy and safety. Therefore, enhanced insight into a drug’s subcellular distribution profile is required, including: (I) the cellular uptake, (II) a drug’s distribution over the various organelles, (III) and the role of organelle transport proteins therein.
QTM’s services aim to contribute to a more efficient drug development process, by quantifying and modeling a drug’s subcellular distribution profile, also referred to as pharmacokinetics 2.0. To do so, we have developed a proprietary label-free method to measure both bound and unbound cytosolic and organelle concentrations. To disentangle the role of organelle transport proteins herein, we provide state-of-the-art services. Finally, QTM provides services to simulate the subcellular drug distribution and consulting to assist your molecular PKPD challenges during drug development.
Thereby, we strive to make drug discovery faster and cheaper, and to prevent unnecessary human and animal studies.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Kloosterstraat 9, Oss,north Brabant 5349ab,netherlands
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- https://www.qtmbiosciences.com
- Keywords
- Oss.
- HQ
- Oss, North Brabant
Qtm Biosciences Questions
Qtm Biosciences's website is https://www.qtmbiosciences.com
Qtm Biosciences's LinkedIn profile is https://nl.linkedin.com/company/qtm-biosciences
Qtm Biosciences has
2 employees.
View email and phone details for 2
employees at Qtm Biosciences.
Qtm Biosciences's industry is
Research Services
Qtm Biosciences's top competitors are
Crossfire Oncology,
Nvf, Nederlandse Vereniging Voor Farmacologie - Dutch Pharmacological Society,
Certara,
Lead Pharma,
Lifesciences@work,
Alnylam Pharmaceuticals,
Nelisca,
Qvq Holding Bv,
Ipa (Immunoprecise Antibodies),
Glycostem Therapeutics.
Qtm Biosciences's categories are Research Services
Qtm Biosciences's founding year is 2023
